NIKKEI 225
38,294.70 +92.33 (+0.24%) HANG SENG
18,415.88 +102.02 (+0.56%) CRUDE OIL
79.29 +0.30 (+0.38%) GOLD FUTURES
2,318.50 -3.80 (-0.16%) DOW
39,056.39 +172.13 (+0.44%) Bitcoin GBP
49,241.16 -786.50 (-1.57%)
MannKind Corporation (MNKD)
After hours:
| Previous close | 4.4700 |
| Open | 4.4700 |
| Bid | 4.3900 x 1000 |
| Ask | 4.4400 x 100 |
| Day's range | 4.3400 - 4.4800 |
| 52-week range | 3.1700 - 5.7500 |
| Volume | |
| Avg. volume | 2,958,040 |
| Market cap | 1.191B |
| Beta (5Y monthly) | 1.32 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0400 |
| Earnings date | 05 Aug 2024 - 09 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 7.08 |
ZacksCompared to Estimates, MannKind (MNKD) Q1 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for MannKind (MNKD) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
ZacksMannKind (MNKD) Beats Q1 Earnings and Revenue Estimates
MannKind (MNKD) delivered earnings and revenue surprises of 150% and 13.76%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
GlobeNewswireMannKind Corporation Reports 2024 First Quarter Financial Results: Provides Clinical Development Update
Conference Call to Begin Today at 5:00 p.m. (ET)1Q 2024 Total revenues of $66M; +63% vs. 1Q 20231Q 2024 Net income of $11M; Non-GAAP net income of $15M$304M of cash and cash equivalents and investments at March 31, 2024In early April, repaid Midcap senior-secured debt and Mann Group convertible debt totaling approximately $37M FDA Fast Track designation and IND clearance received for MNKD-101 DANBURY, Conn. and WESTLAKE VILLAGE, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasd
